Variant report
Variant | nsv520963 |
---|---|
Chromosome Location | chr6:160637239-160638076 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LPA-7 | chr6:160638046-160638530 | NONHSAT115898 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs596881 | chr6:160637239-160637240 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs543480345 | chr6:160637250-160637251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11759226 | chr6:160637289-160637290 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78165183 | chr6:160637329-160637330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76592043 | chr6:160637360-160637361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551763540 | chr6:160637391-160637392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187569193 | chr6:160637393-160637394 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573080891 | chr6:160637423-160637424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs595853 | chr6:160637485-160637486 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs551920119 | chr6:160637542-160637543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559016604 | chr6:160637546-160637547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529716032 | chr6:160637547-160637548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs595374 | chr6:160637562-160637563 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs549543404 | chr6:160637587-160637588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs370822910 | chr6:160637630-160637631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374992402 | chr6:160637640-160637641 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142584860 | chr6:160637648-160637649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192563638 | chr6:160637668-160637669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146008594 | chr6:160637682-160637683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547411207 | chr6:160637698-160637699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs565939654 | chr6:160637800-160637801 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534533389 | chr6:160637826-160637827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557913654 | chr6:160637834-160637835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3127592 | chr6:160637844-160637845 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs536104512 | chr6:160637856-160637857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372349036 | chr6:160637861-160637862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374500566 | chr6:160637871-160637872 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs694812 | chr6:160637890-160637891 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs570704084 | chr6:160637923-160637924 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs184363759 | chr6:160637966-160637967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2450975 | chr6:160637975-160637976 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs3127593 | chr6:160638003-160638004 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs3103353 | chr6:160638076-160638077 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 19459884 | CNVD |
Hearing loss | 19459884 | CNVD |
Microcephaly | 19459884 | CNVD |
Coronary artery disease | 17160897 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:160626800-160639800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr6:160635800-160639800 | Weak transcription | Pancreas | Pancrea |
3 | chr6:160636600-160638400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr6:160637000-160637400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr6:160637000-160639000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr6:160637200-160637400 | Weak transcription | H1 Cell Line | embryonic stem cell |
7 | chr6:160637200-160637400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr6:160637200-160638200 | Weak transcription | Fetal Muscle Leg | muscle |
9 | chr6:160637200-160639600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr6:160637200-160639800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr6:160637400-160642200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr6:160637400-160642800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |